{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:59:33Z","timestamp":1774310373084,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"University Malaya Private Funding","award":["PV023-2017"],"award-info":[{"award-number":["PV023-2017"]}]},{"name":"Australian National Health and Medical Research Council for a Centre of Research Excellence","award":["APP2007007"],"award-info":[{"award-number":["APP2007007"]}]},{"name":"Fundamental Research Grant Scheme, Ministry of Higher Education of Malaysia","award":["FRGS16-048-0547"],"award-info":[{"award-number":["FRGS16-048-0547"]}]},{"name":"Fundamental Research Grant Scheme, Ministry of Higher Education of Malaysia","award":["FRGS16-048-0547"],"award-info":[{"award-number":["FRGS16-048-0547"]}]},{"name":"CRE RESPOND; Australian National Health and Medical Research Council Centre of Research Excellence","award":["APP2007007"],"award-info":[{"award-number":["APP2007007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20630-5","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:18:45Z","timestamp":1761751125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment"],"prefix":"10.1038","volume":"15","author":[{"given":"Helmi","family":"Sulaiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Azrai","family":"Rozali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh K. S.","family":"Adiraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Shahnaz","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janattul A.","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd-Basri","family":"Mat-Nor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Zulfakar","family":"Mazlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Irfan","family":"Othman-Jailani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeti Norfidiyati","family":"Salmuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd H.","family":"Abdul-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"20630_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jac\/dkh511","volume":"55","author":"RG Masterton","year":"2005","unstructured":"Masterton, R. G., Kuti, J. L., Turner, P. J. & Nicolau, D. P. The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe. J. Antimicrob. Chemother. 55, 71\u201377 (2005).","journal-title":"J. Antimicrob. Chemother."},{"key":"20630_CR2","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"JA Roberts","year":"2014","unstructured":"Roberts, J. A. et al. DALI: Defining antibiotic levels in intensive care unit patients: Are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?. Clin. Infect. Dis. 58, 1072\u20131083 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"20630_CR3","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/ciaa224","volume":"72","author":"JA Roberts","year":"2021","unstructured":"Roberts, J. A. et al. The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: Data from the multinational sampling antibiotics in renal replacement therapy study. Clin. Infect. Dis. 72, 1369\u20131378 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"20630_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1164\/rccm.202207-1393OC","volume":"207","author":"K Shekar","year":"2023","unstructured":"Shekar, K. et al. Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenation. Am. J. Respir. Crit. Care Med. 207, 704\u2013720 (2023).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20630_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"JA Roberts","year":"2014","unstructured":"Roberts, J. A. et al. Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions. Lancet. Infect. Dis 14, 498\u2013509 (2014).","journal-title":"Lancet. Infect. Dis"},{"key":"20630_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/antibiotics9030131","volume":"9","author":"C Scharf","year":"2020","unstructured":"Scharf, C. et al. Therapeutic drug monitoring of meropenem and piperacillin in critical illness\u2014Experience and recommendations from one year in routine clinical practice. Antibiotics 9, 131 (2020).","journal-title":"Antibiotics"},{"key":"20630_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig, W. A. Pharmacokinetic\/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26, 1\u201310 (1998).","journal-title":"Clin. Infect. Dis."},{"key":"20630_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jac\/dkf130","volume":"50","author":"VH Tam","year":"2002","unstructured":"Tam, V. H., McKinnon, P. S., Akins, R. L., Rybak, M. J. & Drusano, G. L. Pharmacodynamics of cefepime in patients with Gram-negative infections. J. Antimicrob. Chemother. 50, 425\u2013428 (2002).","journal-title":"J. Antimicrob. Chemother."},{"key":"20630_CR9","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1128\/aac.00294-06","volume":"51","author":"C Li","year":"2007","unstructured":"Li, C., Du, X., Kuti, J. L. & Nicolau, D. P. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob. Agents Chemother. 51, 1725\u20131730. https:\/\/doi.org\/10.1128\/aac.00294-06 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20630_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ijantimicag.2014.12.018","volume":"45","author":"SL Aitken","year":"2015","unstructured":"Aitken, S. L. et al. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin\/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia. Int. J. Antimicrob. Agents 45, 541\u2013544. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.018 (2015).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"20630_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s40262-019-00791-z","volume":"58","author":"CD Sumi","year":"2019","unstructured":"Sumi, C. D., Heffernan, A. J., Lipman, J., Roberts, J. A. & Sime, F. B. What antibiotic exposures are required to suppress the emergence of resistance for gram-negative bacteria?. Syst. Rev. Clin. Pharmacokinet. 58, 1407\u20131443. https:\/\/doi.org\/10.1007\/s40262-019-00791-z (2019).","journal-title":"Syst. Rev. Clin. Pharmacokinet."},{"key":"20630_CR12","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","volume":"42","author":"MH Abdul-Aziz","year":"2016","unstructured":"Abdul-Aziz, M. H. et al. Beta-lactam infusion in severe sepsis (BLISS): A prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive Care Med. 42, 1535\u20131545 (2016).","journal-title":"Intensive Care Med."},{"issue":"8","key":"20630_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"JM Dulhunty","year":"2024","unstructured":"Dulhunty, J. M. et al. Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: The BLING III randomized clinical trial. JAMA. 332(8), 629\u2013637 (2024).","journal-title":"JAMA."},{"issue":"8","key":"20630_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"MH Abdul-Aziz","year":"2024","unstructured":"Abdul-Aziz, M. H. et al. Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: A systematic review and meta-analysis. JAMA. 332(8), 638\u2013648 (2024).","journal-title":"JAMA."},{"key":"20630_CR15","doi-asserted-by":"publisher","first-page":"e01312","DOI":"10.1128\/aac.01312-22","volume":"67","author":"G An","year":"2023","unstructured":"An, G. et al. Evaluation of empirical dosing regimens for meropenem in intensive care unit patients using population pharmacokinetic modeling and target attainment analysis. Antimicrob. Agents Chemother. 67, e01312-01322 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20630_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00228-016-2053-x","volume":"72","author":"F Mattioli","year":"2016","unstructured":"Mattioli, F. et al. Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients. Eur. J. Clin. Pharmacol. 72, 839\u2013848. https:\/\/doi.org\/10.1007\/s00228-016-2053-x (2016).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"20630_CR17","doi-asserted-by":"crossref","unstructured":"Gijsen, M. et al. Meropenem target attainment and population pharmacokinetics in critically ill septic patients with preserved or increased renal function. Infect. Drug Resist., 53\u201362 (2022).","DOI":"10.2147\/IDR.S343264"},{"key":"20630_CR18","doi-asserted-by":"publisher","first-page":"e00845","DOI":"10.1128\/aac.00845-22","volume":"66","author":"A Boonpeng","year":"2022","unstructured":"Boonpeng, A. et al. Population pharmacokinetics\/pharmacodynamics and clinical outcomes of meropenem in critically ill patients. Antimicrob. Agents Chemother. 66, e00845-e1822 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20630_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s13318-021-00709-w","volume":"46","author":"A O\u2019jeanson","year":"2021","unstructured":"O\u2019jeanson, A., Larcher, R., Le Souder, C., Djebli, N. & Khier, S. Population pharmacokinetics and pharmacodynamics of meropenem in critically ill patients: how to achieve best dosage regimen according to the clinical situation. Eur. J. drug metab. Pharmacokinet. 46, 695\u2013705 (2021).","journal-title":"Eur. J. drug metab. Pharmacokinet."},{"key":"20630_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1213\/ANE.0b013e3181ed114e","volume":"112","author":"VM Banz","year":"2011","unstructured":"Banz, V. M., Jakob, S. M. & Inderbitzin, D. Review article: Improving outcome after major surgery: Pathophysiological considerations. Anesth. Analg. 112, 1147\u20131155. https:\/\/doi.org\/10.1213\/ANE.0b013e3181ed114e (2011).","journal-title":"Anesth. Analg."},{"key":"20630_CR21","first-page":"730","volume":"53","author":"M Ishikawa","year":"2006","unstructured":"Ishikawa, M. et al. Postoperative host responses in elderly patients after gastrointestinal surgery. Hepatogastroenterology 53, 730\u2013735 (2006).","journal-title":"Hepatogastroenterology"},{"key":"20630_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","volume":"49","author":"AA Udy","year":"2010","unstructured":"Udy, A. A., Roberts, J. A., Boots, R. J., Paterson, D. L. & Lipman, J. Augmented renal clearance: Implications for antibacterial dosing in the critically ill. Clin. Pharmacokinet. 49, 1\u201316 (2010).","journal-title":"Clin. Pharmacokinet."},{"key":"20630_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijantimicag.2013.02.023","volume":"42","author":"S Adnan","year":"2013","unstructured":"Adnan, S. et al. Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains. Int. J. Antimicrob. Agents 42, 90\u201393 (2013).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"20630_CR24","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","volume":"286","author":"FL Ferreira","year":"2001","unstructured":"Ferreira, F. L., Bota, D. P., Bross, A., M\u00e9lot, C. & Vincent, J. L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286, 1754\u20131758. https:\/\/doi.org\/10.1001\/jama.286.14.1754 (2001).","journal-title":"JAMA"},{"key":"20630_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/ccm.0000000000002210","volume":"45","author":"JA Roberts","year":"2017","unstructured":"Roberts, J. A., Kumar, A. & Lipman, J. Right dose, right now: Customized drug dosing in the critically Ill. Crit. Care Med. 45, 331\u2013336. https:\/\/doi.org\/10.1097\/ccm.0000000000002210 (2017).","journal-title":"Crit. Care Med."},{"key":"20630_CR26","doi-asserted-by":"publisher","first-page":"106868","DOI":"10.1016\/j.ijantimicag.2023.106868","volume":"62","author":"S Tournayre","year":"2023","unstructured":"Tournayre, S. et al. Factors associated with meropenem pharmacokinetic\/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion. Int. J. Antimicrob. Agents 62, 106868. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106868 (2023).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"20630_CR27","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/jac\/dky370","volume":"73","author":"R Burger","year":"2018","unstructured":"Burger, R. et al. Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections. J. Antimicrob. Chemother. 73, 3413\u20133422. https:\/\/doi.org\/10.1093\/jac\/dky370 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"20630_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.2023.10598","volume":"330","author":"G Monti","year":"2023","unstructured":"Monti, G. et al. Continuous vs intermittent meropenem administration in critically ill patients with sepsis: The MERCY randomized clinical trial. JAMA 330, 141\u2013151 (2023).","journal-title":"JAMA"},{"key":"20630_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","volume":"387","author":"R Laxminarayan","year":"2016","unstructured":"Laxminarayan, R. et al. Access to effective antimicrobials: A worldwide challenge. Lancet 387, 168\u2013175 (2016).","journal-title":"Lancet"},{"key":"20630_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/jac\/dky434","volume":"74","author":"SAM Dhaese","year":"2018","unstructured":"Dhaese, S. A. M. et al. Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: A comparison of eight pharmacokinetic models. J. Antimicrob. Chemother. 74, 432\u2013441. https:\/\/doi.org\/10.1093\/jac\/dky434 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"20630_CR31","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/jac\/dkx209","volume":"72","author":"S Imani","year":"2017","unstructured":"Imani, S., Buscher, H., Marriott, D., Gentili, S. & Sandaradura, I. Too much of a good thing: A retrospective study of \u03b2-lactam concentration\u2013toxicity relationships. J. Antimicrob. Chemother. 72, 2891\u20132897 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"20630_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"20630_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J. E. APACHE II: A severity of disease classification system. Crit. Care Med. 13, 818\u2013829 (1985).","journal-title":"Crit. Care Med."},{"key":"20630_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft, D. W. & Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31\u201341. https:\/\/doi.org\/10.1159\/000180580 (1976).","journal-title":"Nephron"},{"key":"20630_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"key":"20630_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey, A. S. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann. Intern. Med. 130, 461\u2013470. https:\/\/doi.org\/10.7326\/0003-4819-130-6-199903160-00002 (1999).","journal-title":"Ann. Intern. Med."},{"key":"20630_CR37","unstructured":"(FDA), U. S. D. o. H. a. H. S. F. a. D. A., (CDER), C. f. D. E. a. R. & (CVM), C. f. V. M. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CMV), 2018. (2018)."},{"key":"20630_CR38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz, M. H. et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: A position paper. Intensiv. Care Med. 46, 1127\u20131153 (2020).","journal-title":"Intensiv. Care Med."},{"key":"20630_CR39","unstructured":"James S. Lewis II, A. J. M., et al. Performance Standards for Antimicrobial Susceptibility Testing (Edition 34th). (2024)."},{"key":"20630_CR40","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, http:\/\/www.eucast.org\/clinical_breakpoints\/ (2024)."},{"key":"20630_CR41","first-page":"697","volume-title":"In Kucers\u2019 The Use of Antibiotics","author":"AY Peleg","year":"2017","unstructured":"Peleg, A. Y. & Harris, P. N. In Kucers\u2019 The Use of Antibiotics 697\u2013722 (CRC Press, 2017)."},{"key":"20630_CR42","doi-asserted-by":"crossref","unstructured":"Delyon, B., Lavielle, M. & Moulines, E. Convergence of a stochastic approximation version of the EM algorithm. Annal. Stat., 94\u2013128 (1999).","DOI":"10.1214\/aos\/1018031103"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20630-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20630-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20630-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:18:53Z","timestamp":1761751133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20630-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20630"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20630-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37781"}}